(Q54599109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

E Herrmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

N Marschner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

C H Ohlmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

U Hutzschenreuter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

F Overkamp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M Groschek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

K Blumenstengel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

G Pühse

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

T Steiner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

3 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

361-366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00345-011-0673-4

27 January 2020

exact match

0 references

cites work

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Sequential sorafenib and sunitinib for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Is advanced renal cell carcinoma becoming a chronic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-011-0673-4

10.1007/S00345-011-0673-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21461939%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference